Circulating miRNAs are Down-regulated in Asthmatic Patients; Case-control Study.

Area of Science:

• Biochemistry
• Molecular Biology
• Pulmonology

Background:

• MicroRNAs (miRNAs) are crucial non-invasive biomarkers for inflammatory diseases.
• Understanding miRNA expression profiles can predict disease activity in conditions like asthma.

Purpose of the Study:

• To investigate differential miRNA expression profiles in asthma patients versus healthy controls (HC).
• To identify potential circulating miRNA biomarkers for asthma prediction.

Main Methods:

• Evaluated 84 miRNAs in plasma from asthma patients and HC using real-time PCR.
• Validated observed miRNA expression changes in an independent cohort.
• Assessed correlations between miRNA levels, BMI, and FEV1.

Main Results:

• Asthma patients exhibited significantly lower levels of miR-17-5p, miR-106b-5p, and miR-126-3p compared to HC.
• miR-223-3p levels were also lower in asthma patients, though not statistically significant (p=0.13).
• No significant correlations were found between the studied miRNAs and BMI or FEV1.

Conclusions:

• Circulating miRNAs, including miR-17-5p, miR-106b-5p, and miR-126-3p, may serve as valuable biomarkers for asthma prediction.
• Further research is warranted to explore the diagnostic and prognostic utility of these miRNAs in asthma.